Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07521267

Nano Coated Orthodontic Miniscrews for en Mass Retraction of the Upper Arch

Evaluation of Silver-Hydroxyapatite Nano-coated Versus Uncoated Orthodontic Miniscrews for en Masse Retraction of the Upper Anterior Segment: A Randomized Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
14 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
14 Years – 20 Years
Healthy volunteers
Not accepted

Summary

study will be directed to evaluate silver-hydroxyapatite nano-coated versus uncoated orthodontic miniscrews for en masse retraction of the upper anterior segment.

Detailed description

Silver-hydroxyapatite nanoparticles (Ag-HA NPs) have lately gained popularity in dentistry due to their unique combination of silver antibacterial activity and hydroxyapatite's osteoconductive, remineralizing characteristics. Ag-HA has shown potential in resolving two important clinical issues: infection control and anchoring stability. Coating orthodontic miniscrews with Ag-HA NPs has been demonstrated to reduce peri-implant biofilm growth by their antimicrobial effect, minimizing inflammation, and increasing osseointegration, thus increasing the long-term success of temporary anchoring devices (TADs).

Conditions

Interventions

TypeNameDescription
DEVICESilver nanoparticlesPatients will receive silver-hydroxyapatite nanocoated titanium miniscrews.These miniscrews will be placed in the maxillary bone for en masse retractonof the upper anterior teeth.
DEVICEuncoated titanium miniscrewsPatients will receive conventional uncoated titanium miniscrews of the same dimensions and design as the intervention of the group1, but without nano-coating.

Timeline

Start date
2026-05-01
Primary completion
2028-06-01
Completion
2029-11-01
First posted
2026-04-09
Last updated
2026-04-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07521267. Inclusion in this directory is not an endorsement.